PhenixFIN (NYSE:PFX) Stock Gets Downgrade from Zacks Research

PhenixFIN (NYSE:PFX – Get Free Report) was downgraded by equities researchers at Zacks Research from a “strong-buy” rating to a “hold” rating in a report issued on Monday, Zacks reports.

PhenixFIN Stock Performance

NYSE:PFX opened at $44.59 on Monday. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.87. The company has a market capitalization of $86.10 million, a P/E ratio of 5.47 and a beta of 0.32. The firm has a 50-day moving average price of $46.72 and a two-hundred day moving average price of $43.70. PhenixFIN has a twelve month low of $38.30 and a twelve month high of $56.48.

Institutional Investors Weigh In On PhenixFIN

A hedge fund recently bought a new stake in PhenixFIN stock. Legal & General Group Plc bought a new stake in PhenixFIN Co. (NYSE:PFX – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 15,140 shares of the company’s stock, valued at approximately $655,000. Legal & General Group Plc owned approximately 0.78% of PhenixFIN as of its most recent SEC filing. 43.35% of the stock is owned by hedge funds and other institutional investors.

PhenixFIN Company Profile

(Get Free Report)

PhenixFIN Corporation (NYSE:PFX) is a business development company (BDC) that provides financing to privately owned, middle-market companies. The company seeks to generate income and long-term capital appreciation by investing in businesses that may have limited access to traditional sources of capital.

PhenixFIN primarily invests in senior secured loans, including first-lien and unitranche facilities, as well as second-lien and subordinated debt. It may also make equity investments and acquire other securities in connection with its financing activities.

Featured Articles

Receive News & Ratings for PhenixFIN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PhenixFIN and related companies with MarketBeat.com's FREE daily email newsletter.